A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF EFLORNITHINE WITH LOMUSTINE COMPARED TO LOMUSTINE ALONE IN PATIENTS WITH ANAPLASTIC ASTROCYTOMA THAT PROGRESS/RECUR AFTER IRRADIATION AND ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY - STELLAR STUDY

Registry ID

OT-15-001

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

ORBUS THERAPEUTICS INC

Start date

2017-12-12

Last update

2017-03-31

Conditions

• ANAPLASTIC ASTROCYTOMA

Related clinical trials

• PHASE 2/3 RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511, A RETROVIAL REPLICATING VECTOR, COMBINED WITH TOCA FC VERSUS STANDARD OF CARE IN SUBJECTS UNDERGOING PLANNED RESECTION FOR RECURRENT GLIOBLASTOMA OR ANAPLASTIC ASTROCYTOMA."

View on source registry